A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma

Genes Chromosomes and Cancer

Volumn 48, Issue 9, 2009, Pages 777-785

  Fehr, André ^a   Meyer, Anke ^a   Heidorn, Klaus ^b   Röser, Kerstin ^c   Löning, Thomas ^d   Bullerdiek, Jörn ^a,e  

^a UNIVERSITY OF BREMEN   (Germany)

^b Institute of Haematopathology   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d ALBERTINEN KRANKENHAUS   (Germany)

^e UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRTC1 MAML2 FUSION GENE; EMBRYONIC STEM CELL; FEMALE; FUSION GENE; GENE; GENE FUSION; GENE OVEREXPRESSION; HMGA2 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, MUCOEPIDERMOID; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HMGA2 PROTEIN; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PAROTID GLAND; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 68549140268     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20682     Document Type: Article

References (67)

1. Antonov J, Goldstein DR, Oberli A, Baltzer A, Pirotta M, Fleischmann A, Altermatt HJ, Jaggi R. 2005. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85:1040-1050.
2. Auclair PL, Goode RK, Ellis GL. 1992. Mucoepidermoid carcinoma of intraoral salivary glands evaluation and application of grading criteria in 143 cases. Cancer 69:2021-2030.
3. Behboudi A, Winnes M, Gorunova L, van den Oord JJ, Mertens F, Enlund F, Stenman G. 2005. Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion. Genes Chromosomes Cancer 43:202-205.
4. Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Makitie A, Grenman R, Mark J, Stenman G. 2006. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45:470-481.
5. Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J. 2008. Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47:56-63.
6. Bell D, Luna MA, Weber RS, Kaye FJ, El-Naggar AK. 2008. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: Evidence for a common genetic association. Genes Chromosomes Cancer 47:309-314.
7. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A. 1995. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15:1545-1553.
8. Bullerdiek J, Raabe G, Bartnitzke S, Boschen C, Schloot W. 1987. Structural rearrangements of chromosome Nr 8 involving 8q12-A primary event in pleomorphic ademona of the parotid gland. Genetica 72:85-92.
9. Bullerdiek J, Haubrich J, Meyer K, Bartnitzke S. 1988. Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet Cytogenet 35:129-132.
10. Bullerdiek J, Vollrath M, Wittekind C, Caselitz J, Bartnitzke S. 1990. Mucoepidermoid tumor of the parotid gland showing a translocation (3;8)(p21;q12) and a deletion (5)(q22) as sole chromosome abnormalities. Cancer Genet Cytogenet 50:161-164.
11. Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, Bartnitzke S. 1993. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: Correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65:27-31.
12. Bustin M, Reeves R. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54:35-100.
13. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A, Fusco A. 1996. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13:2439-2446.
14. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M. 2003. TORCs: transducers of regulated CREB activity. Mol Cell 12:413-423.
15. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ. 2005. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65:7137-7144.
16. El-Naggar AK. 2006. Clear cell hidradenoma of the skin-A third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion: Genes Chromosomes Cancer. 2005; 43:202-205. Adv Anat Pathol 13:80-82.
17. Enlund F, Behboudi A, Andren Y, Oberg C, Lendahl U, Mark J, Stenman G. 2004. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 292:21-28.
18. Fehr A, Roser K, Belge G, Loning T, Bullerdiek J. 2008a. A closer look at Warthin tumors and the t(11;19). Cancer Genet Cytogenet 180:135-139.
19. Fehr A, Roser K, Heidorn K, Hallas C, Loning T, Bullerdiek J. 2008b. A new type of MAML2 fusion in mucoepidermoid carcinoma. Genes Chromosomes Cancer 47:203-206.
20. Fonseca I, Fonseca R, Martins C, Soares J. 2008. Alteration of bcatenin localization in salivary pleomorphic adenomas is not related to t(3;8)(p21;q12) and is mainly present in non-epithelial cell types. Histopathology 52:244-247.
21. Geurts JM, Schoenmakers EF, Roijer E, Stenman G, van de Ven WJ. 1997. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res 57:13-17.
22. Geurts JM, Schoenmakers EF, Roijer E, Astrom AK, Stenman G, van de Ven WJ. 1998. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene 16:865-872.
23. Goode RK, El Naggar AK. 2005. Mucoepidermoid carcinoma. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumors. Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press, pp. 219-220.
24. Goode RK, Auclair PL, Ellis GL. 1998. Mucoepidermoid carcinoma of the major salivary glands: Clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 82:1217-1224.
25. Gross KL, Neskey DM, Manchanda N, Weremowicz S, Kleinman MS, Nowak RA, Ligon AH, Rogalla P, Drechsler K, Bullerdiek J, Morton CC. 2003. HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 38:68-79.
26. Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H. 1998. The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 23:350-357.
27. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, Orth AP, Miraglia L, Meltzer J, Garza D, Chirn GW, McWhinnie E, Cohen D, Skelton J, Terry R, Yu Y, Bodian D, Buxton FP, Zhu J, Song C, Labow MA. 2003. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 100:12147-12152.
28. Kasamatsu A, Endo Y, Uzawa K, Nakashima D, Koike H, Hashitani S, Numata T, Urade M, Tanzawa H. 2005. Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses. Int J Biochem Cell Biol 37:1869-1880.
29. Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJ, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J. 1996. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: A survey of 30 tumors. Oncogene 12:515-521.
30. Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ. 2006. Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25:6128-6132.
31. Langelotz C, Schmid P, Jakob C, Heider U, Wernecke KD, Possinger K, Sezer O. 2003. Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br J Cancer 88:1406-1410.
32. Lin SE, Oyama T, Nagase T, Harigaya K, Kitagawa M. 2002. Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J Biol Chem 277:50612-50620.
33. Liu X, Adams AL. 2007. Mucoepidermoid carcinoma of the bronchus: A review. Arch Pathol Lab Med 131:1400-1404.
34. Malek A, Bakhidze E, Noske A, Sers C, Aigner A, Schäfer R, Tchernitsa O. 2008. HMGA2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer 123:348-356.
35. Mark J, Dahlenfors R. 1986. Cytogenetical observations in 100 human benign pleomorphic adenomas: Specificity of the chromosomal aberrations and their relationship to sites of localized oncogenes. Anticancer Res 6:299-308.
36. Mark J, Sandros J, Wedell B, Stenman G, Ekedahl C. 1988. Significance of the choice of tissue culture technique on the chromosomal patterns in human mixed salivary gland tumors. Cancer Genet Cytogenet 33:229-244.
37. Martins C, Cavaco B, Tonon G, Kaye FJ, Soares J, Fonseca I. 2004. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn 6:205-210.
38. Meyer B, Krisponeit D, Junghanss C, Escobar HM, Bullerdiek J. 2007a. Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: Correlation between HMGA2 expression and white blood cell count. Leuk Lymphoma 48:2008-2013.
39. Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J. 2007b. HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 46:503-511.
40. Mitelman Database of Chromosome Aberrations in Cancer. 2009.Mitelman F, Johansson B, Mertens F, editors. Available at: http://cgap.nci.nih.gov/ Chromosomes/Mitelman.
41. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K. 2004. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 64:2024-2029.
42. Nance MA, Seethala RR, Wang Y, Chiosea SI, Myers EN, Johnson JT, Lai SY. 2008. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer 113:2082-2089.
43. Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Eimoto T, Nakamura S, Nagai N, Hasegawa Y, Inagaki H. 2006. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res 12:3902-3907.
44. Pentimalli F, Dentice M, Fedele M, Pierantoni GM, Cito L, Pallante P, Santoro M, Viglietto G, Dal Cin P, Fusco A. 2003. Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2. Cancer Res 63:7423-7427.
45. Persson F, Andrén Y, Winnes M, Wedell B, Nordkvist A, Gudnadottir G, Dahlenfors R, Sjögren H, Mark J, Stenman G. 2009. High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2. Genes Chromosomes Cancer 48:69-82.
46. Reeves R, Nissen MS. 1990. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 265:8573-8582.
47. Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J. 1996. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149:775-779.
48. Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdiek J. 1997. Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: Relationship to histologic grade. Mol Carcinog 19:153-156.
49. Rogalla P, Drechsler K, Schroder-Babo W, Eberhardt K, Bullerdiek J. 1998. HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res 18:3327-3330.
50. Roijer E, Kas K, Behrendt M, Van de Ven W, Stenman G. 1999. Fluorescence in situ hybridization mapping of breakpoints in pleomorphic adenomas with 8q12-13 abnormalities identifies a subgroup of tumors without PLAG1 involvement. Genes Chromosomes Cancer 24:78-82.
51. Roijer E, Nordkvist A, Strom AK, Ryd W, Behrendt M, Bullerdiek J, Mark J, Stenman G. 2002. Translocation, deletion/ampli-fication, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol 160:433-440.
52. Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, Bullerdiek J. 1997. HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma. 26:603-607.
53. Rutherford S, Hampton GM, Frierson HF, Jr., Moskaluk CA. 2005. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma. Lab Invest 85:1076-1085.
54. Sarhadi VK, Wikman H, Salmenkivi K, Kuosma E, Sioris T, Salo J, Karjalainen A, Knuutila S, Anttila S. 2006. Increased expression of high mobility group A proteins in lung cancer. J Pathol 209:206-212.
55. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ. 1995. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-444.
56. Sezer O, Langelotz C, Blohmer JU, Schmid P, Akrivakis K, Possinger K. 2000. Detection of HMGI-C in the peripheral blood of breast cancer patients. Eur J Cancer 36:1944-1948.
57. Stenman G, Mark J. 1983. Specificity of the involvement of chromosomes 8 and 12 in human mixed salivary-gland tumours. J Oral Pathol 12:446-457.
58. Stenman G, Petursdottir V, Mellgren G, Mark J. 1998. A child with a t(11;19)(q14-21;p12) in a pulmonary mucoepidermoid carcinoma. Virchows Arch 433:579-581.
59. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. 2007. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 46:708-715.
60. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. 2003. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33:208-213.
61. Wanschura S, Kazmierczak B, Schoenmakers E, Meyen E, Bartnitzke S, Van de Ven W, Bullerdiek J, Schloot W. 1995. Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15. Genes Chromosomes Cancer 14: 68-70.
62. Winkler S, Murua Escobar H, Meyer B, Simon D, Eberle N, Baumgartner W, Loeschke S, Nolte I, Bullerdiek J. 2007. HMGA2 expression in a canine model of prostate cancer. Cancer Genet Cytogenet 177:98-102.
63. Winnes M, Molne L, Suurkula M, Andren Y, Persson F, Enlund F, Stenman G. 2007. Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer 46:559-563.
64. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. 2000. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26:484-489.
65. Wu L, Sun T, Kobayashi K, Gao P, Griffin JD. 2002. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 22:7688-7700.
66. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, Griffin JD. 2005. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24:2391-2402.
67. Zhou X, Chada K. 1998. HMGI family proteins: Architectural transcription factors in mammalian development and cancer. Keio J Med 47:73-77.